Sign in

    Doug O’Bannon

    Research Analyst at Private Investor

    Doug O’Bannon is a Research Analyst at Private Investor, with a focus on biotechnology and healthcare sectors. He has specifically covered companies such as Adicet Bio and has engaged in earnings call discussions, demonstrating a targeted approach to emerging biopharma equities. While direct performance metrics and rankings are not publicly available, his participation in corporate research highlights industry engagement and analytical experience. Details about his career timeline, previous firms, and professional credentials such as FINRA registration or securities licenses are not found in available public records.

    Doug O’Bannon's questions to Adicet Bio (ACET) leadership

    Doug O’Bannon's questions to Adicet Bio (ACET) leadership • Q1 2019

    Question

    Doug O’Bannon, a private investor, expressed concern about the falling stock price and asked if the company was worried about the possibility of being de-listed.

    Answer

    CFO Becky Roof responded directly that the company is not concerned about the stock being de-listed at this point in time.

    Ask Fintool Equity Research AI